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Abstract
Backgroud: Pancreatic cancer is a highly malignant tumor of the digestive system. This secretome of pancreatic
cancer is key to its progression and metastasis. But different methods of protein extraction affect the final results. In
other words, the real secretion of proteins in cancer cells has been changed. Based on mass spectrometry, we
analyze the secretome from the serum-containing and serum-free medium, using different protein pretreatment
methods. This study aims to identify dissociation factors in pancreatic cancer.
Methods: In this study, pancreatic cancer cells were cultured in serum-containing or serum-free medium, and the
corresponding supernatants were extracted as samples. Subsequently, the above samples were separated by size
exclusion chromatography (SEC), and peptide segments were identified by LC-MS/MS. The final results were
identified via the hamster secreted protein database and a public database.
Results: Although the number of identified proteins in the serum-free medium group was high, the real secretion
of proteins in pancreatic cancer cells was changed. There were six significant secreted proteins in the serum-
containing medium group. Survival analysis via the TCGA database suggested that patients with higher expression
levels of YWHAG showed a worse overall survival rate than those with lower YWHAG expression.
Conclusions: Our study demonstrated the results in the serum-containing medium group were more similar to the
real secretome of pancreatic cancer cells. YWHAG could be used as a prognostic indicator for pancreatic cancer.
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Background
Pancreatic cancer is the fourth leading cause of cancer
death worldwide and is characterized by rapid progres-
sion, high invasiveness, and resistance to chemothera-
peutic drugs. The latest survey of malignant tumors in
China showed that the mortality rate of pancreatic
cancer ranks sixth [1–3]. More than 80% of patients with
pancreatic cancer are diagnosed with local invasion or
even distant metastasis. Theoretically, the possibility of
surgical resection is lost, and only palliative treatment is
tolerated [4]. In addition, patients undergoing radical
surgery have a median survival time of only 18 months
[5]. Early diagnosis and appropriate treatment can
significantly improve the prognosis of pancreatic cancer.
With the development of experimental techniques, the
number of molecular detection methods for cancer is
increasing. These methods play an important role in the
early diagnosis of pancreatic cancer [6]. In a previous
study, we used two cell lines derived from the hamster
model of pancreatic cancer that have distinct invasion
and metastasis abilities: a nondissociated, low-metastasis
pancreatic cancer cell line (PC-1) and a dissociated,
high-metastasis pancreatic cancer cell line (PC-1.0).
Conditioned medium was prepared from the purified
supernatant of PC-1.0 cells and used to culture PC-1
cells. The growth state of PC-1 cells was changed and
exhibited the growth state of PC-1.0 cells. Therefore, we
concluded that the supernatant of PC-1.0 cells contains
key factors that can promote changes in cell biological
behavior, which we call dissociation factors (DF) [7, 8].
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The purpose of this experiment was to identify dissoci-
ation factors by using different sample pretreatment
methods combined with size exclusion chromatography.
Methods
Cell lines and cell culture
PC-1 cells grew as islet-like colonies of cells, whereas PC-
1.0 cells grew as single cells. The source and incubation
conditions of the cells were described previously [9].
Materials
Acetonitrile (ACN) and methanol were purchased from
Merck Company (Germany); glacial acetic acid, from
Damao Chemical Reagent Factory in Tianjin; and bovine
serum albumin (BSA), from Sigma-Aldrich Company
(USA). Trypsin (bovine pancreas), formic acid, trifluor-
oacetic acid, urea, protease inhibitor cocktail,
dithiothreitol, trichloroacetic acid, acetone, and iodoace-
tamide were purchased from Sigma–Aldrich (St. Louis,
MO, USA). All experimental water was purified by a
Milli-Q system (Millipore Corporation, USA). A Thermo
SEC120 HPLC column (5 μm, 120 Å) was used. An
Ultimate 3000 chromatograph and Thermo LTQ-Orbitrap
mass spectrometer were used for detection.
Effects of serum-free conditioned medium from PC-1.0
cells on the activity of PC-1 cells
Preparation of serum-free conditioned medium: Three
methods were used to prepare conditioned medium
from PC-1.0 cells, which was used to treat cultured PC-1
cells for 24 h; then, morphological changes in PC-1 cells
were observed. The following methods were used:
Method 1: PC-1.0 cells were washed 5 times with PBS;
Method 2: PC-1.0 cells were washed 3 times with PBS
Fig. 1 Flowchart of sample procedures used in this study. Serum-free medium group were divided three group using different treated serum
starvation. For Sample 1, a large number PC-1 cells died after incubation with conditioned medium from Sample 1. The results show that the
serum starvation affect the condition, maybe undergo apoptosis, so the subsequent experiment exclude the Sample1
Fig. 2 Changes in PC-1.0 cells after serum starvation observed by microscopy
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and incubated 2 times with phenol-free medium (Gibco,
Grand Island, NY) for 20 min each; And Method 3: PC-
1.0 cells were incubated in 2% PBS + phenol-free
medium for 20 min and in phenol-free medium 4 times
for 20 min each. The supernatants of the above samples
were extracted and used to prepare the culture medium.
Extraction of total protein from samples
PC-1.0 cell and PC-1 cell supernatants and RPMI 1640
medium (negative control group) were extracted as
samples 4, 5 and 6 in the serum-containing medium ex-
perimental group. Each sample was spun at 12000 r/min
through a 0.22 μm fiber filter and concentrated using a
3 kDa concentrating tube by centrifuging at 3500×g for
120 min. The protein concentration was measured using
the BCA method.
SEC-RPLC-MS/MS analysis
Low-abundance proteins were enriched on a size exclu-
sion chromatography (SEC) column. The 200 μl sample
was washed for 10 min with buffer A at a flow rate of
0.5 ml/min. After collecting the effluent components, the
remaining fractions were eluted with buffer B at a flow
rate of 1 ml/min for 7 min, and the collected fractions
were stored at − 20 °C for use. The effluent components
collected were centralized in a rotary concentrator with
a 5 kDa molecular weight cutoff membrane and centri-
fuged at 10 °C for 5000 r/min. Samples were collected
for subsequent application.
An Ultimate 3000 chromatograph and a Thermo LTQ-
Orbitrap mass spectrometer were used for detection.
Peptides were loaded on an in-house-packed C18 capillary
trap column (150 μm i.d. × 4 cm) and separated using a
C18 separation column (75 μm i.d. × 15 cm). Phase A was
98% H2O + 2% ACN with 0.1% FA, and phase B was 2%
H2O + 98% ACN with 0.1% FA. The gradient was as fol-
lows: 0–6% phase B for 10min, 6–35% phase B for 100
min, 35–80% phase B for 10min, and 80% phase B for 10
min. The temperature of the ion transfer capillary was set
at 275°Cwith a spray voltage of 2.7 kV. The scan range
was set from m/z = 300–1800.There was a 20 s exclusion
window. Raw spectrum data were searched using Mascot
(2.3.2). For classifying the obtained protein results, the
database species used in the experiment were both ham-
ster and bovine. Mass tolerances were set at 7 ppm for
parent ions and 20 ppm for fragments. The fixed modifi-
cation was cysteine alkylation, and the variable
Fig. 3 PC-1 cell morphology 12 h after the addition of PC-1.0 supernatant. A large number of PC-1 cells died after incubation with conditioned
medium from Sample 1; the number of PC-1 cells after incubation with Sample 2 medium exhibited a relative decrease, and there was no
obvious separation trend; and the growth status of PC-1 cells after treatment with Sample 3 medium changed.
Table 1 Protein spectrum data results
Species Sample Protein Hamster Hamster - secreted protein Bovine
No. 2 1378 987 99 391
No. 3 1496 1092 111 404
No. 4 230 62 25 168
No. 5 284 105 28 179
No. 6 236 65 21 171
Fig. 4 The results of MS in the serum-containing group were shown
by a Venn diagram. As a result, 14 protein only exists in the
supernatant of PC-1.0 cell lines. Among them, 6 protein, which
contain values, may be as candidate DFs
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modification was methionine oxidation. The maximum
number of missing cleavage sites was 2, and the FDR was
controlled at less than 1%.
Bioinformatic analysis
Because special structural characteristics of secreted pro-
teins usually include a signal peptide, SignalP4.1 soft-
ware was used to search the current hamster protein
database and to construct the hamster secreted protein
database (http://www.cbs.dtu.dk/services/SignalP/, prob-
ability > 0.90) [10]. In the serum-containing medium
group, RPMI 1640 medium was used as the negative
control to eliminate the error caused by unlabeled sam-
ples. The results were screened from the database of
hamster secretory proteins. Subsequently, the DAVID
(http://david.abcc.ncifcrf.gov/) [11] and STING (https://
string-db.org/) [12] bioinformatics software tools were
used to analyze protein functions and possible inter-
acting proteins. Finally, Survival analysis of patients with
the different DFs was analyzed with Kaplan Meier
Plotter (http://kmplot.com/analysis/index.php?p=servi-
ce&cancer=pancancer_rnaseq) [13]. The Gene Expres-
sion Profiling Interactive Analysis (GEPIA) database was
used to analyze the expression of the target genes in the
TCGA database (http://gepia.cancer-pku.cn/) [14]. The
expression level of YWHAG in different cancer stages
was analyzed with the online analysis platform UALCAN
(http://ualcan.path.uab.edu/index.html) [15].
YWHAG uptake assay
Western blotting was performed as described previously
[9]. Primary antibodies against YWHAG and β-actin
(Abcam, USA) were used. Samples with equivalent
amounts of total protein (20 μg) were loaded. Western
blot signals were quantified using an Amersham Imager
600 (GE Healthcare, Little Chalfont, UK), and band signals
were expressed as relative protein amounts compared to
Table 2 DAVID Cluster Analysis
Enrichment Score: 1.9097618864692167
Category Term P-Value
UP_KEYWORDS Secreted 3.83E-04
UP_SEQ_FEATURE disulfide bond 0.001971
UP_SEQ_FEATURE signal peptide 0.003347
UP_KEYWORDS Disulfide bond 0.003354
GOTERM_CC_DIRECT GO:0005615~extracellular space 0.003597
GOTERM_CC_DIRECT GO:0005576~extracellular region 0.006005
UP_KEYWORDS Signal 0.006989
Fig. 5 STRING software predicts protein-protein interactions. To further analyze the interaction between the identified proteins, we used the
STRING database to retrieve the six proteins.(YWHAG, MMP12, MMP10, LAMA5, CPN1 and F5)
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β-actin. The purified supernatant from PC-1.0 cells were
added to PC-1 cells at 60–70% confluence. The YWHAG
protein level of the PC-1 cells was tested by western blot
analysis after another 24 h of culture. Human pancreatic
cancer cell lines AsPC-1 and Capan-2, which have mor-
phological and functional characteristics similar to PC-1.0
and PC-1 cells, respectively, were used to determine if the
results from hamster cells coincide with human pancreatic
cancer cell lines.
Statistical analysis
Statistical analyses were conducted and graphics were
generated using GraphPad Prism 6.0. P < 0.05 was con-
sidered statistically significant in this study. Comparisons
of quantitative data were made using Student’s t-test.
Results
Biological functional validation of serum-free culture
conditions
According to the purpose of this study, samples of highly
invasive PC-1.0 cells were processed and divided into the
serum-free and serum-containing groups (Fig. 1). In the
serum-free group, PC-1.0 cells were treated with three
different serum starvation methods, and the cell content
of sample 1 was the lowest (Fig. 2). Subsequently, we ex-
tracted the corresponding supernatant to prepare condi-
tioned medium and incubated PC-1 cells with this
medium. It was found that a large number of PC-1 cells
died after incubation with conditioned medium from
Sample 1; the number of PC-1 cells after incubation with
Sample 2 medium exhibited a relative decrease, and there
was no obvious separation trend; and the growth status of
PC-1 cells after treatment with Sample 3 medium changed
(Fig.3). Therefore, the serum-free treatment process
changed the composition of the original supernatant,
which may lead to errors in the final analysis results.
Identification of DFs
According to the biological function verification results,
samples 2 and 3 were subjected to subsequent mass
spectrometry verification (Additional file 1). From the
serum-containing medium experimental group, samples
4, 5 and 6 were taken for follow-up experiments. Each
group was separated by SEC and analyzed by mass spec-
trometry. The results were searched by Mascot software.
The database species used were hamsters and cattle. The
Fig. 6 Survival analysis of patients with 5 DFs in the TCGA database. YWHAG can be used as a prognostic indicator for pancreatic cancer. (P =
0.00091, FDR < 10%). The FDR of MMP12 and LAMA5 is over 50%. F5 were detected in database
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results were then searched to generate the database of
hamster secreted proteins (see Table 1, Additional files 2
and 3). The results showed that the number of secreted
proteins in samples 4, 5 and 6 was small, which indi-
cated that the serum had a great influence on the num-
ber of final identified proteins, but the results were more
authentic and more conducive to further verification
than those from the serum-free groups. The data from
the serum-containing experimental groups were inte-
grated and analyzed. Only 6 secretory proteins were
expressed in PC-1.0cells: matrix metalloelastase 12
(MMP12), matrix metalloproteinase 1 (stromelysin-2,
MMP10), laminin subunit alpha-5 (LAMA5), Tyr-3/Trp-
5 monooxygenase activator protein gamma (14–3-3 eta,
YWHAG), carboxypeptidase N catalytic chain (CPN1)
and coagulation factor V (THPH2) (Fig. 4).
Identification of YWHAG as a prognostic biomarker of
pancreatic cancer
Through online functional annotation cluster analysis
with DAVID software, the secretory signal cluster was
found (enrichment score: 1.91, Table 2). To further
analyze the interaction between the identified proteins,
we used the STRING database to retrieve the above six
proteins (Fig. 5). We used online software to perform
clinical correlation analysis of these six proteins. The re-
sults showed that YWHAG could be used as a prognos-
tic biomarker for pancreatic cancer (Fig. 6). We used the
Cancer Genome Atlas (TCGA) data visualization web
tool GEPIA to analyze the expression of YWHAG in
normal and cancer tissues. The results showed higher
expression levels of YWHAG in pancreatic cancer than
Fig. 7 Expression level of YWHAG in pancreatic cancer and normal
tissue in the TCGA database
Fig. 8 Expression level of YWHAG in different individual pancreatic cancer stages in the TCGA database
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in normal tissue in the TCGA cohort (P < 0.01) (Fig. 7).
Validation of the YWHAG expression level in different
cancer stages from TCGA data showed higher expres-
sion levels of YWHAG in the advanced stage than in the
early stage (Fig. 8). The Western blot results showed that
YWHAG was highly expressed in the highly invasive
PC-1.0 cell line (Fig. 9). The expression level of YWHAG
in PC-1 cells increased with the increase of cocultured
PC-1.0-derived DF (Fig. 10).
Discussion
With the development of mass spectrometry technology, a
large number of secreted proteins have been identified.
These newly discovered proteins have been shown to be
tumor markers [16]. When tumor cells secrete proteins
into the extracellular environment, some of these proteins
can change the tumor microenvironment and promote
tumor growth [17]. In our previous work, we found that
the supernatant of highly invasive PC-1.0 cells contained
DFs. DFs can induce morphologic changes in and increase
the invasive ability of low-invasive PC-1 cells. DFs play an
important role in understanding the molecular mechan-
ism of invasion and metastasis of cancer cells. In this
study, we identified DFs using a mass spectrometry-based
proteomic approach.
In this study, two different pretreatment methods were
used to isolate samples by combined size exclusion
chromatography (SEC) and to preliminarily analyze the
secreted proteomes of pancreatic cancer cell lines. The
results showed 1496 identified proteins in the serum-free
medium group and 230 in the serum-contained medium
group. In the serum-free experimental group, we found
that the short-term serum starvation process can lead to
changes in the secretory status. Therefore, the secretory
status in serum-containing culture medium is more similar
to the real secretory status and is thus more meaningful for
later clinical verification and application. In the serum-
containing medium group, we used SEC to isolate and
enrich the secreted proteins in the supernatant. Although
there was no quantitative data, the secreted proteins were
also qualitatively identified through data mining and
analysis. Six proteins were identified, namely, MMP12,
MMP10, LAMA5, YWHAG, CPN1 and THPH2. Among
these six proteins, MMP12 and MMP10 are members of
the matrix metalloproteinase family, and have been proven
to be closely related to pancreatic cancer [18, 19]. LAMA5
is an important component of the extracellular matrix,
which can regulate cell adhesion and promote cancer cell
metastasis [20]. CPN1 can prevent the accumulation of
polypeptides and regulate the secretory hormone level [21].
Baine MJ et al. reported that the level of coagulation factor
V was found to be significantly different in an analysis of
peripheral monocytes from pancreatic cancer patients and
might be related to tumor stage [22]. YWHAG is a mem-
ber of a highly conserved family of proteins that partici-
pates in many intracellular signal transduction processes
and plays an important role in cell survival and prolifera-
tion [23–26]. However, the role of YWHAG in pancreatic
Fig. 9 YWHAG protein levels were detected using western blot analysis. a, Western blot validation of YWHAG from cells lines. b, Quantitative
analysis of YWHAG is shown. *P < 0.05,**P < 0.01, ***P < 0.001
Fig. 10 The expression level of YWHAG in PC-1 cells increased with
the increase of cocultured PC-1.0-derived DF. **P < 0.01
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cancer progression is still unclear. In our previous intracel-
lular proteomic study, YWHAG was also the key gene in
the PPI network [9]. The expression of YWHAG was
found to be closely related to pancreatic cancer stage via
TCGA database analysis. Furthermore, survival analysis
suggested that patients with higher expression levels of
YWHAG showed a worse overall survival rate than those
with lower YWHAG expression.
Conclusion
Given the above findings, several alternative proteins were
identified as pancreatic cancer dissociation factors via a
pair of homologous pancreatic cancer cell lines with dif-
ferent metastatic abilities. These results provided us with
more comprehensive information on pancreatic cancer in-
vasion and metastasis. YWHAG is suggested as a potential
prognostic biomarker and a sensitive therapeutic target
for pancreatic cancer invasion and metastasis.
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